SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001437749-24-002311
Filing Date
2024-01-26
Accepted
2024-01-26 17:27:09
Documents
1
Effectiveness Date
2024-01-26

Document Format Files

Seq Description Document Type Size
1 FORM S-8 POS navb20240126h_s8pos.htm S-8 POS 32681
  Complete submission text file 0001437749-24-002311.txt   33858
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-217814 | Film No.: 24569264
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)